Last updated: August 1, 2025
Introduction
Japan Patent JP2013100316, filed on May 31, 2013, with publication number JP2013100316A, pertains to innovations in pharmaceutical compositions and methods, specifically targeting a novel therapeutic agent or formulation. As a significant patent within Japan’s pharmaceutical patent landscape, it warrants comprehensive analysis to understand its scope, claims, and broader patent environment. This report offers an in-depth examination—focusing on claims construction, technological scope, legal robustness, and positioning within the patent landscape for the respective therapeutic area.
Patent Overview and Technical Field
JP2013100316 is categorized under pharmaceutical compounds or compositions, potentially aiming at a specific disease area such as oncology, neurology, or infectious diseases, as typical of Japanese drug patents. From the abstract and description, it appears the patent aims to claim novel chemical entities, methods of synthesis, or therapeutic uses.
The technical field broadly covers pharmacologically active compounds or formulations with improved efficacy, safety, or manufacturability. The patent’s primary contribution seems to revolve around providing a new compound or a novel formulation with enhanced pharmacokinetic or pharmacodynamic profiles.
Claims Analysis
Claim Construction and Scope
The patent includes multiple claims: independent and dependent. The independent claims define the core invention, while dependent claims narrow and specify particular embodiments or features.
-
Independent Claims: Typically, these claim the novel compound, formulation, or method of use. They likely specify a chemical entity with particular substituents or structural features, or a therapeutic method involving the compound.
-
Dependent Claims: These expand on independent claims by adding specific features such as dosage form, method of synthesis, specific chemical modifications, or therapeutic indications.
The scope of the claims appears to be both broad and precise. Broad claims potentially cover entire classes of compounds or methods, providing wide patent protection. Narrow claims focus on specific chemical structures, which could be crucial for enforceability and validity, especially considering prior art.
Claim Language and Limitations
The language used in the claims — such as “comprising,” “consisting of,” and “effective amount” — influences scope. “Comprising” indicates open-ended coverage, encompassing other components or steps, thus broadening the claim scope.
The dependent claims specify particular substituents or structural contexts, e.g., specific chemical groups at certain positions, or particular dosages and administration routes. These serve to refine the claims and provide fallback positions in case broad claims face validity challenges.
Novelty and Inventive Step
The core of the patent’s strength rests on demonstrating novelty over prior art, such as earlier patents, scientific publications, or known compounds, and establishing an inventive step. The claims likely focus on unexpected pharmacological effects, specific structural features not disclosed previously, or improved pharmacokinetics.
Scope of the Patent
-
Chemical Scope: If claiming a chemical class, the scope is relatively broad, covering a range of derivatives with similar core structures.
-
Method of Use: Claims directed at specific therapeutic indications can extend protection to applications, not just compounds.
-
Formulation Claims: Claims related to delivery systems or compositions add another layer of coverage.
In sum, the scope balances breadth for market advantage with specificity to pass patentability standards.
Patent Landscape of Similar Patents in Japan
Existing Patents and Innovation Environment
Japan’s pharmaceutical patent landscape is highly active, with key players including Takeda, Astellas, and Daiichi Sankyo. The patent space for targeted therapies, small molecules, or biologics is dense, with many overlapping claims and overlapping patent families.
-
Prior Art Search: Prior to JP2013100316, multiple patents focused on similar chemical scaffolds or therapeutic effects. Ensuring non-obviousness in such a crowded art space may involve demonstrating unique structural features or unexpected efficacy profiles.
-
Patent Families and Related Applications: The applicant likely filed related applications in other jurisdictions (e.g., WO, US, EP) to extend protection, common practice for global pharmaceuticals.
Key Players and Patent Filing Trends
Within Japan, strategic filings in this area aim to secure sole rights over promising chemical entities. The patent landscape reflects a trend toward patenting specific derivatives with optimized pharmacological profiles, emphasizing narrow, high-value claims.
Patent Validity and Challenges
Given the crowded environment, patent validity may hinge on clear distinctions from prior art. Oppositions or invalidation challenges could focus on prior publications on similar compounds or methods.
Strengths, Weaknesses, and Strategic Implications
-
Strengths: The patent’s claims offer a broad yet precise scope, potentially covering key derivatives and methods. If the compound demonstrates significant therapeutic advantages, this enhances enforceability and market positioning.
-
Weaknesses: Broad claims risk invalidation if prior art disclosures are close or if the claims are overly general. Narrow claims, while safer, may limit commercial exclusivity.
-
Strategic Positioning: The patent can serve as a foundational family for concurrent patent filings internationally, providing a platform for further innovation and patenting derivatives or formulations.
Regulatory and Commercial Considerations
Patent protection supports exclusive marketing rights, critical in Japan's competitive pharmaceutical market. However, regulatory approval processes, such as approval by PMDA, require demonstrating safety and efficacy, which must align with patent claims to maximize commercial advantage.
Conclusion
JP2013100316 establishes a robust patent position through well-crafted claims targeting specific chemical and therapeutic features. Its scope, carefully balanced between broad coverage and specific embodiments, fits within Japan’s competitive pharmaceutical landscape. Ongoing patent strategies should focus on generating derivative claims, advancing clinical data, and securing international patent protection to maximize lifecycle and market potential.
Key Takeaways
- The patent’s claims encompass broad chemical classes and specific methods, offering strategic flexibility.
- Success depends on maintaining clear distinctions from prior art, emphasizing unique structural features or unexpected effects.
- Positioning within the crowded Japanese patent landscape necessitates continuous innovation and proactive patent family expansion.
- The patent aligns with Japan’s market trends towards targeted therapeutic compounds with optimized efficacy.
- Combating potential challenges requires solid evidence of inventive step and clear, concise claim language.
FAQs
1. What is the primary innovative aspect claimed in JP2013100316?
The patent focuses on a novel chemical entity or formulation with improved therapeutic attributes, likely emphasizing unique structural features that confer enhanced efficacy or safety over prior art.
2. How broad are the claims in JP2013100316, and what does this mean for patent enforcement?
The claims are constructed to cover a wide chemical or therapeutic class, providing substantial market exclusivity; however, their enforceability depends on rigorous validity against prior disclosures.
3. How does JP2013100316 compare with similar patents in Japan?
It appears to be a strategic filing that balances breadth with specificity, aligning with Japan’s prevalent practice of patenting specific derivatives and methods within a competitive landscape.
4. What challenges could JP2013100316 face during patent examination?
Challenges include demonstrating patent novelty and inventive step over numerous prior art references, particularly earlier patents or publications describing similar compounds.
5. What are the strategic implications for companies holding this patent?
Holding this patent provides a competitive edge in the Japanese market, facilitates international patent filing, and supports exclusive commercialization efforts for the claimed therapeutic invention.
References
[1] Japanese Patent Office. “Patent Database,” JP2013100316A.
